MUMBAI — Piramal Pharma Limited has announced that Ms. Nandini Piramal will continue to steer the company’s strategic direction following her re-appointment to the board. Effective April 1, 2026, she assumes the role of Whole-Time Director, designated as Executive Director and Chairperson.
